Cargando…

Efficacy and Safety of Sugammadex versus Neostigmine in Reversing Neuromuscular Blockade in Morbidly Obese Adult Patients: A Systematic Review and Meta-Analysis

CONTEXT: Sugammadex is known to reverse neuromuscular blockade (NMB) more rapidly and reliably than neostigmine. However, data remain limited in bariatric patients. In this review, we systematically evaluated the efficacy and safety of sugammadex versus neostigmine in reversing NMB in morbidly obese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subramani, Yamini, Querney, Jill, He, Susan, Nagappa, Mahesh, Yang, Homer, Fayad, Ashraf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462431/ https://www.ncbi.nlm.nih.gov/pubmed/34667357 http://dx.doi.org/10.4103/aer.aer_79_21

Ejemplares similares

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
por: Ren, Maodong, et al.
Publicado: (2020)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
por: Paredes, Stephania, et al.
Publicado: (2023)

Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Chowdhury, Sumit Roy, et al.
Publicado: (2023)

Reply to the Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Paredes, Stephania, et al.
Publicado: (2023)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
por: Cheong, Soon Ho, et al.
Publicado: (2015)

Effects of Neostigmine and Sugammadex for Reversal of Neuromuscular Blockade on QT Dispersion Under Propofol Anesthesia: A Randomized Controlled Trial
por: Yamashita, Yusuke, et al.
Publicado: (2018)

Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine.
por: Lemmens, Hendrikus JM, et al.
Publicado: (2010)

Effect of neuromuscular reversal with neostigmine/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery
por: Traeger, L., et al.
Publicado: (2022)

Cost-Effectiveness of Sugammadex Versus Neostigmine to Reverse Neuromuscular Blockade in a University Hospital in Taiwan: A Propensity Score-Matched Analysis
por: Lan, Winnie, et al.
Publicado: (2023)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
por: Aouad, Marie T., et al.
Publicado: (2017)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Quality of Recovery after Laparoscopic Cholecystectomy Following Neuromuscular Blockade Reversal with Neostigmine or Sugammadex: A Prospective, Randomized, Controlled Trial
por: Han, Jiwon, et al.
Publicado: (2021)

Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects
por: Wu, Xinmin, et al.
Publicado: (2014)

Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery
por: Oh, Tak Kyu, et al.
Publicado: (2020)

Successful Neuromuscular Blockade Reversal Using Sugammadex and Neostigmine Failed to Prevent Myasthenic Crisis After Emergency Surgery: A Case Report
por: Haddad, Daniel, et al.
Publicado: (2022)

Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade
por: Luo, Jie, et al.
Publicado: (2018)

Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center
por: Fiorda Diaz, Juan, et al.
Publicado: (2022)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
por: Alsaeed, Abdulhamid, et al.
Publicado: (2017)

Effects of Sugammadex and Neostigmine on Renal Biomarkers
por: Isik, Yasemin, et al.
Publicado: (2016)

Retrospective evaluation of the effects of sugammadex and neostigmine on the IgE and eosinophil cationic protein in morbid obese patients
por: Gorgulu, Ozkan, et al.
Publicado: (2020)

The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex
por: Oh, Tak Kyu, et al.
Publicado: (2019)

Impact of Sugammadex Versus Neostigmine/Glycopyrrolate on Perioperative Efficiency
por: Deyhim, Niaz, et al.
Publicado: (2020)

Incidence, Risk Factors, and Outcomes of Perioperative Atrial Fibrillation following Noncardiothoracic Surgery: A Systematic Review and Meta-Regression Analysis of Observational Studies
por: Subramani, Yamini, et al.
Publicado: (2021)

A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada
por: Insinga, Ralph P., et al.
Publicado: (2016)

Influence of sugammadex versus neostigmine for neuromuscular block reversal on the incidence of postoperative pulmonary complications: a meta-analysis of randomized controlled trials
por: Wang, Jia-Feng, et al.
Publicado: (2021)

Is neostigmine safe and effective for neuromuscular blockade reversal in patients recovering from general anesthesia?
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial
por: Schepens, Tom, et al.
Publicado: (2019)

Efficacy and safety of sugammadex doses calculated on the basis of corrected body weight and total body weight for the reversal of deep neuromuscular blockade in morbidly obese patients
por: Li, Deming, et al.
Publicado: (2021)

Reply to “Is neostigmine safe and effective for neuromuscular blockade reversal in patients recovering from general anesthesia?”
por: Ji, Wentao, et al.
Publicado: (2022)

Required dose of sugammadex or neostigmine for reversal of vecuronium‐induced shallow residual neuromuscular block at a train‐of‐four ratio of 0.3
por: He, Jing, et al.
Publicado: (2021)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Sugammadex, a Neuromuscular Blockade Reversal Agent, Causes Neuronal Apoptosis in Primary Cultures
por: Palanca, José M., et al.
Publicado: (2013)

Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017)

Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
por: Trifa, Mehdi, et al.
Publicado: (2017)

Comparison of neostigmine and sugammadex for hemodynamic parameters in neurointerventional anesthesia
por: Tsai, Yu-Hsun, et al.
Publicado: (2023)

Effects of Sugammadex versus Neostigmine on Intraoperative Coagulation Profiles in Patients with Thyroidectomy
por: Zhao, Dizhou, et al.
Publicado: (2021)

Neostigmine versus sugammadex on post-operative recovery following bariatric surgery
por: Ekinci, Osman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ad78lbtcllflo1ld90uf5eclkn